‹ PACB latest research

PACB (Pacific Biosciences of Californ): every AI call and what happened next

TradeFlare's AI research teams analysed PACB on 8 market nights between June 5, 2026 and October 8, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

8 calls 1 BUY · 7 HOLD · 0 SELL BUY calls up after 20 trading days: 1 of 1
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
October 8, 2026 HOLD $2.72 — / — not yet not yet
The stock is currently extended and showing high volatility, making it unsuitable for a new entry.
October 7, 2026 HOLD $2.70 $3.24 / $2.29 not yet not yet
The PEAD signal suggests a short-term continuation, but fundamental weakness and risk flags warrant a cautious approach.
October 6, 2026 HOLD $2.87 — / — -24.1% not yet
The current setup does not warrant a buy, and the stock's high volatility and risk profile necessitate a cautious approach.
October 5, 2026 HOLD $2.54 $2.92 / $2.16 -26.8% not yet
The PEAD signal suggests short-term momentum, but fundamental concerns and price state warrant a cautious approach.
September 30, 2026 HOLD $1.83 — / — +14.8% not yet
The current setup does not warrant a trade.
September 29, 2026 HOLD $1.71 — / — +47.5% not yet
The current setup does not warrant a buy, and the market regime is neutral.
August 6, 2026 HOLD $1.30 — / — -1.7% +11.1%
The 8-K filing regarding workforce reduction could signal a strategic shift towards cost discipline, potentially improving margins.
June 5, 2026 BUY $1.63 — / — -9.7% +7.6%
Post-earnings drift signal from the scanner.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.